It is important for the cancer team to be able to recognize what a small cell might look like — such as central location of the tumor, bulky adenopathy generally.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
It is important for the cancer team to be able to recognize what a small cell might look like — such as central location of the tumor, bulky adenopathy generally. Sometimes patients present with unexplained weight loss and/or hemoptysis because of the central location of the tumor. It is important to be able to pick up on risk factors and understand the importance from symptoms to diagnosis and diagnosis to treatment. CANCER BUZZ spoke to Adam Fox, MD, Pulmonologist, Medical University of South Carolina in Charleston, South Carolina. Listen as Dr. Fox discusses the importance of recognizing and diagnosing small cell lung cancer (SCLC).
Adam Fox, MD
Pulmonologist
Medical University of South Carolina
Charleston, SC
“In most patients, while small cell only accounts for 10% to 15% of all lung cancers, almost all patients with small cell lung cancer have a smoking history…”
“Fundamentals for anyone with lung cancer is to pick that biopsy site that is going to provide the diagnosis, at least some stage information, and any tissue needed for extra stains (to confirm the diagnosis), or mostly the case for non-small cell lung cancer, biomarker testing for making treatment decisions.”
ACCC’s SCLC program is supported by AstraZeneca and G1 Therapeutics.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
